HSD17B3 rs74315359: Understanding the Genetic Basis of 17β-HSD3

What each genotype means

What is the HSD17B3 Gene?

The HSD17B3 gene, located on chromosome 9, encodes the enzyme 17β-hydroxysteroid dehydrogenase type 3. This enzyme is primarily active in the testes, where it performs the final step in the biosynthesis of testosterone by converting the precursor hormone androstenedione into active testosterone. Testosterone is essential for the development of male reproductive structures during fetal life and for the maintenance of male characteristics throughout adulthood. Because this enzyme is highly specialized for testicular function, the gene is expressed predominantly in Leydig cells. When the HSD17B3 gene is altered, the resulting enzyme may have reduced or absent activity, which can disrupt the normal hormonal environment required for typical male sexual development.

Understanding the rs74315359 Variant

The variant rs74315359 is a specific single-nucleotide change within the HSD17B3 gene. In the context of clinical genetics, this variant is categorized as pathogenic, meaning it is known to cause or contribute to a specific health condition. When an individual inherits two copies of a pathogenic variant in this gene—one from each parent—it leads to 17β-hydroxysteroid dehydrogenase 3 deficiency. This condition is an autosomal recessive disorder, meaning that individuals who carry only one copy of the variant are typically unaffected, as the single functional copy of the gene is usually sufficient to produce enough enzyme for normal development. The variant is studied by researchers to understand how specific molecular changes in the DNA sequence translate into the loss of enzymatic function.

Clinical Associations and Evidence

Research has established a strong link between pathogenic variants in HSD17B3 and a condition known as 46,XY disorder of sex development (DSD). Individuals with this condition have XY chromosomes but may exhibit undermasculinized external genitalia at birth because their bodies cannot produce sufficient testosterone during critical windows of fetal development. Clinical hallmarks often include a decreased ratio of testosterone to androstenedione in the blood, particularly after puberty when the testes attempt to produce more androgens. The evidence for the pathogenicity of variants in this gene is well-documented in clinical databases like ClinVar. It is important to note that while genetic testing can identify these variants, the clinical presentation can vary significantly between individuals, and any medical concerns should be discussed with a qualified healthcare provider or genetic counselor.

Population Frequency and Distribution

The rs74315359 variant is considered rare in the general global population. However, its frequency is not uniform across all groups. In some populations, particularly within specific Middle Eastern communities, the variant has been observed at higher frequencies due to founder effects. A founder effect occurs when a small group of people establishes a population, leading to a higher prevalence of certain genetic variants that were present in the original founders. Because of this, the condition associated with this variant is more frequently diagnosed in these specific ancestral groups. Outside of these populations, the variant is extremely uncommon. Understanding these patterns helps clinicians provide more accurate risk assessments and genetic counseling for families with a history of reproductive development conditions.

What You Can Do With This Information

Genetic information regarding variants like rs74315359 is primarily used in clinical settings to help diagnose the underlying cause of reproductive development differences. If you or a family member have received results indicating the presence of this variant, it is essential to consult with a medical professional, such as a clinical geneticist or an endocrinologist. They can help interpret what these results mean in the context of your specific health history and provide guidance on appropriate clinical management or testing for other family members. This information is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or genetic test results.

Frequently asked questions

Sources & further reading